US48208B2034
US48208B2034
Jupiter Neurosciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.76M EUR | 10.32M EUR | 13.64M EUR | 35.14M EUR |
Enterprise Value | 2.36M EUR | 10.55M EUR | 16.11M EUR | 36.67M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 47.5x | -- | -- | -- |
Price to Sales | 58.09x | 159.52x | 337.27x | 1,612.01x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 36.49x | 163.03x | 398.34x | 1,682.21x |
EV/EBITDA | -- | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -86.79% | -70.25% | -42.39% | -12.38% |